Literature DB >> 28097380

Successful treatment of pouchitis with Vedolizumab, but not fecal microbiota transfer (FMT), after proctocolectomy in ulcerative colitis.

Mona Schmid1, Julia-Stefanie Frick2, Nisar Malek1, Martin Goetz3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28097380     DOI： 10.1007/s00384-017-2761-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  4 in total

1.  European evidence based consensus for endoscopy in inflammatory bowel disease.

Authors:  Vito Annese; Marco Daperno; Matthew D Rutter; Aurelien Amiot; Peter Bossuyt; James East; Marc Ferrante; Martin Götz; Konstantinos H Katsanos; Ralf Kießlich; Ingrid Ordás; Alessandro Repici; Bruno Rosa; Shaji Sebastian; Torsten Kucharzik; Rami Eliakim
Journal:  J Crohns Colitis       Date:  2013-11-01       Impact factor: 9.071

2.  Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report.

Authors:  Shuyang Fang; Colleen S Kraft; Tanvi Dhere; Jahnavi Srinivasan; Beth Begley; David Weinstein; Virginia O Shaffer
Journal:  Int J Colorectal Dis       Date:  2015-11-03       Impact factor: 2.571

3.  Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis.

Authors:  J Landy; A W Walker; J V Li; H O Al-Hassi; E Ronde; N R English; E R Mann; D Bernardo; S D McLaughlin; J Parkhill; P J Ciclitira; S K Clark; S C Knight; A L Hart
Journal:  Sci Rep       Date:  2015-08-12       Impact factor: 4.379

Review 4.  Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Authors:  Yanqiang Shi; Yiwei Dong; Wenhui Huang; Decong Zhu; Hua Mao; Peizhu Su
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240
  4 in total
  11 in total

1.  Successful treatment of chronic refractory pouchitis with vedolizumab.

Authors:  Fazia Mir; Mohamad Hasan Yousef; Edward Kenneth Partyka; Veysel Tahan
Journal:  Int J Colorectal Dis       Date:  2017-07-11       Impact factor: 2.571

2.  Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.

Authors:  Bram Verstockt; Charlotte Claeys; Gert De Hertogh; Gert Van Assche; Albert Wolthuis; André D'Hoore; Séverine Vermeire; Marc Ferrante
Journal:  United European Gastroenterol J       Date:  2019-08-20       Impact factor: 4.623

3.  Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

Authors:  Martin Gregory; Kimberly N Weaver; Patrick Hoversten; Stephen Bradley Hicks; Devin Patel; Matthew A Ciorba; Alexandra M Gutierrez; Poonam Beniwal-Patel; Sowmya Palam; Gaurav Syal; Hans H Herfarth; George Christophi; Laura Raffals; Edward L Barnes; Parakkal Deepak
Journal:  Inflamm Bowel Dis       Date:  2019-08-20       Impact factor: 5.325

4.  Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study.

Authors:  Daniel Selvig; Yvette Piceno; Jonathan Terdiman; Martin Zydek; Sarah E Umetsu; Dana Balitzer; Doug Fadrosh; Kole Lynch; Brandon Lamere; Tom Leith; Zain Kassam; Kendall Beck; Sara Lewin; Averil Ma; Ma Somsouk; Susan V Lynch; Najwa El-Nachef
Journal:  Dig Dis Sci       Date:  2019-07-13       Impact factor: 3.199

Review 5.  Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly.

Authors:  James Q Zhou; Sean Michael Duenas; Tarik Kirat; Feza Remzi; Shannon Chang
Journal:  Curr Treat Options Gastroenterol       Date:  2018-09

6.  Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Katleen Vrankx; Jørgen Engberg; Alice Friis-Møller; Jørn Brynskov; Inge Nordgaard-Lassen; Andreas Munk Petersen; Karen Angeliki Krogfelt
Journal:  Front Med (Lausanne)       Date:  2018-11-20

7.  Vedolizumab for chronic antibiotic-refractory pouchitis.

Authors:  Amandeep Singh; Freeha Khan; Rocio Lopez; Bo Shen; Jessica Philpott
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-01-31

8.  α4β7 Integrin Antagonist Vedolizumab for the Treatment of Refractory Ileitis.

Authors:  Rafał Filip; Błażej Goliat; Małgorzata Dziechciaż; Piotr Dąbrowski; Michał Osuchowski; Piotr Paluszkiewicz
Journal:  Case Rep Gastrointest Med       Date:  2019-04-22

9.  α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis.

Authors:  Michaela Melde; Tanja M Müller; Ines Schneider; Carol-Immanuel Geppert; Laura Mühl; Laura Besendorf; Clarissa Allner; Emily Becker; Imke Atreya; Francesco Vitali; Raja Atreya; Markus F Neurath; Sebastian Zundler
Journal:  Therap Adv Gastroenterol       Date:  2021-11-24       Impact factor: 4.409

Review 10.  Medical treatment of pouchitis: a guide for the clinician.

Authors:  Wendy Rabbenou; Shannon Chang
Journal:  Therap Adv Gastroenterol       Date:  2021-06-27       Impact factor: 4.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.